The Effect of Managed Care on the Pharmaceutical Industry
dc.contributor.advisor | Hutt, Peter Barton | en_US |
dc.contributor.author | Carson, Cheryl J. | en_US |
dc.date.accessioned | 2012-07-06T21:28:33Z | |
dc.date.issued | 1997 | en_US |
dc.identifier.citation | The Effect of Managed Care on the Pharmaceutical Industry (1997 Third Year Paper) | en |
dc.identifier.uri | http://nrs.harvard.edu/urn-3:HUL.InstRepos:8965565 | |
dc.description.abstract | The pharmaceutical industry has transformed itself in response to the growth of managed care, which developed as a method to contain the costs of health care. Under the traditional fee-for-service system of practicing medicine, doctors practiced medicine without incentives to reduce the costs imposed on patients, their insurers, and the health care system. Most doctors practiced independently and were reimbursed for each service rendered by passive insurance companies. Shielded from the oversight of third-party intermediaries, doctors had financial incentives to provide more services, regardless of whether those services were therapeutically necessary. | en |
dc.language.iso | en_US | en |
dash.license | LAA | en_US |
dc.subject | Food and Drug Law | en |
dc.subject | managed care | en |
dc.subject | human drugs | en |
dc.subject | pharmaceutical industry | en |
dc.title | The Effect of Managed Care on the Pharmaceutical Industry | en |
dc.type | Paper (for course/seminar/workshop) | en_US |
dc.date.available | 2012-07-06T21:28:33Z | |
dash.authorsordered | false |
Files in this item
This item appears in the following Collection(s)
-
HLS Student Papers [498]